Promising treatments are coming: a message to lymphoma and CLL patients
The world is changing and in the next decade cancer treatment is sure to be completely changed. Speaking from the American Society of Hematology (ASH) 2017 Annual Meeting and Exposition in Atlanta, GA, George Follows, BMBCh, PhD, FRCP, FRCPath, of Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK, gives a positive message to lymphoma and chronic lymphocytic leukemia (CLL) patients. Dr Follows emphasizes the exciting time that this is for research, with novel drugs moving through to licensing and the clinic.
Related videos
1:34
Patient support NETworks: the NeuroEndocrine Tumor (NET) Patient Foundation
Catherine Bouvier
5:44
What is the best therapy for a young patient with relapsed/refractory CLL?
Jacqueline Barrientos
1:49
Encouraging patients to ask about clinical trials
Simon Rule
1:32
Patient advocacy: an essential role
Catherine Bouvier
1:55
Developing breast cancer patient support, awareness, and education
Jo Taylor
